The current landscape of factor XI inhibitors

Anticoagulant therapy has always been tightly connected with bleeding risk, as two sides of the same coin. New insights in thrombosis and hemostasis prompted the development of intrinsic pathway inhibitors that promise to uncouple thrombosis and hemostasis. Treating and preventing thrombotic complic...

Full description

Bibliographic Details
Published in:Thrombosis Update
Main Authors: Matthias M. Engelen, Charlotte Van Edom, Andreas Verstraete, Peter Verhamme, Thomas Vanassche
Format: Article
Language:English
Published: Elsevier 2024-06-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666572724000130